Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc. > Aphria Rating change April 11 to April 17

<< Previous

Bullboard Posts

Next >>

Comment by skyplton Apr 13, 2021 6:52am

154 Views

Post# 32983405

RE:Aphria Rating change April 11 to April 17

Thanks Dave for this. Disappointed, but not surprised. Zamparo's 6 dollar haircut seems harsh. I believe 24CDN is realistic.

DaveInCalgary wrote:
Ratings change for Apr. 11, 2021 - Apr. 17, 2021

Date Symbol Brokerage Analyst Name 'Analyst Ranking out of 7,431' Rating Current Target

12 Apr. 2021 CAAPHA Alliance Global Aaron Grey 370 BUY $24.00CA

12 Apr. 2021 USAPHA Alliance Global Aaron Grey 370 BUY $19.12US

12 Apr. 2021 CAAPHA CIBC John Zamparo 1,327 BUY $28.00CA
12 Apr. 2021 USAPHA CIBC John Zamparo 1,327 BUY $22.31US

11 Apr. 2021 CAAPHA BMO Tamy Chen 6,728 HOLD $21.34CA
11 Apr. 2021 USAPHA BMO Tamy Chen 6,728 HOLD $17.00US